Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products. It produces chemically synthesized drugs in the form of tablets, capsules, and injections for patients facing diseases in the areas of oncology, hematology, immunology, cardiovascular, and neuroscience. The company offers products such as Eliquis, Opdivo, Orencia, Sprycel, Reblozyl, Abecma, Opdualag, etc. BMS serves the healthcare industry.